GAG
MRNA icon

GM Advisory Group’s Moderna MRNA Stock Holding History

GM Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,631
Closed -$250K – 198
2023
Q1 		$250K Sell
1,631
-50
-3% -$8.25K 0.02% 167
2022
Q4 		$302K Buy
+1,681
New +$275K 0.03% 139
2022
Q3 		– Sell
-1,650
Closed -$236K – 195
2022
Q2 		$236K Buy
+1,650
New +$236K 0.04% 160
2022
Q1 		– Sell
-1,213
Closed -$308K – 214
2021
Q4 		$308K Sell
1,213
-40
-3% -$11.7K 0.03% 156
2021
Q3 		$482K Hold
1,253
– – 0.05% 128
2021
Q2 		$294K Sell
1,253
-847
-40% -$151K 0.03% 164
2021
Q1 		$275K Hold
2,100
– – 0.03% 163
2020
Q4 		$219K Buy
+2,100
New +$212K 0.03% 159

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GM Advisory Group's MRNA Position: Q2 2023 in Review

GM Advisory Group sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,631 shares — an estimated $250K sold.

GM Advisory Group first reported a position in MRNA in Q4 2020 and held it in 8 quarters. The position peaked at $482K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • GM Advisory Group reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • GM Advisory Group sold 1,631 Moderna shares in Q2 2023, an estimated $250K.
  • GM Advisory Group first reported a position in Moderna in Q4 2020 and held it in 8 quarters.
  • GM Advisory Group's Moderna position peaked at $482K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on GM Advisory Group's 13F filing for Q2 2023, filed 14 Aug 2023.